These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1679210)

  • 1. Buspirone and related compounds as alternative anxiolytics.
    Taylor DP; Moon SL
    Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of azapirones on serotonin1A neurons of the dorsal raphe.
    Matheson GK; Pfeifer DM; Weiberg MB; Michel C
    Gen Pharmacol; 1994 Jul; 25(4):675-83. PubMed ID: 7958728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of anxiolytics and their therapeutic use].
    Tada K
    Ryoikibetsu Shokogun Shirizu; 2003; (38):608-11. PubMed ID: 12877061
    [No Abstract]   [Full Text] [Related]  

  • 5. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and development of anxiolytics in Japan.
    Yamawaki S
    Eur Neuropsychopharmacol; 1999 Dec; 9 Suppl 6():S413-9. PubMed ID: 10622688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azapirones for generalized anxiety disorder.
    Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
    Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT.
    Gilbert F; Dourish CT
    Psychopharmacology (Berl); 1987; 93(3):349-52. PubMed ID: 2893412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxytryptamine1A receptor-mediated effects of buspirone, gepirone and ipsapirone.
    Koenig JI; Meltzer HY; Gudelsky GA
    Pharmacol Biochem Behav; 1988 Apr; 29(4):711-5. PubMed ID: 2901112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buspirone, a new approach to the treatment of anxiety.
    Taylor DP
    FASEB J; 1988 Jun; 2(9):2445-52. PubMed ID: 2836252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors.
    Yocca FD
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):6S-12S. PubMed ID: 1973941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new generation of serotonergic anxiolytics: possible clinical roles.
    Eison MS
    Psychopathology; 1989; 22 Suppl 1():13-20. PubMed ID: 2567037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine effects of azapirones.
    Cowen PJ; Anderson IM; Grahame-Smith DG
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):21S-25S. PubMed ID: 1973937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies.
    Kędzierska E; Fiorino F; Gibuła E; Corvino A; Giordano F; Herbet M; Dudka J; Poleszak E; Wlaź P; Kotlińska JH
    Fundam Clin Pharmacol; 2019 Jun; 33(3):254-266. PubMed ID: 30506804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Azaspirodecanodiones in clinical psychiatry].
    Conde López V; Martínez Roig M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(4):155-67. PubMed ID: 1356293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new approach to innovating selective anxiolytics: pharmacological profile of a novel 5-HT1A agonist (tandospirone)].
    Sasa M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):53-9. PubMed ID: 9201724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's conflict test.
    Söderpalm B; Hjorth S; Engel JA
    Pharmacol Biochem Behav; 1989 Jan; 32(1):259-65. PubMed ID: 2567524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of animal models: toward anxioselective drugs.
    Eison MS
    Psychopathology; 1984; 17 Suppl 1():37-44. PubMed ID: 6143343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.